Silence Therapeutics plc (SLN) operating margin

Operating margin · fiscal 2025
-16056.0%

Silence Therapeutics plc (SLN) had an operating margin of -16056.0% in fiscal 2025 (the year ended December 31, 2025). That is 15909.6 percentage points lower than the -146.4% of fiscal 2024. Figures as of 18 Nov 2026, 13:09 UTC, from Yahoo Finance.

Key facts

Operating margin, fiscal 2025
-16056.0%
Change on fiscal 2024
−15909.6 pts
Highest on record
-146.4%fiscal 2024
Lowest on record
-16056.0%fiscal 2025
Fiscal years on record
42022–2025

Figures as of . Statements from Yahoo Finance. Figures, not advice.

Silence Therapeutics plc operating margin, in more detail

Across the 4 fiscal years on record (2022–2025), the highest was -146.4% in fiscal 2024 and the lowest -16056.0% in fiscal 2025. The fiscal 2025 figure is no higher than in any of the 3 earlier fiscal years on record, whose median is -203.5%.

Gross margin was 61.5% in fiscal 2025. Net margin was -15851.9% in fiscal 2025.

History · 4 fiscal years

Operating margin by fiscal year

  • Operating margin
  • Gross margin
  • Net margin

Silence Therapeutics plc operating margin, year by year

Silence Therapeutics plc (SLN) operating margin by fiscal year
Fiscal yearOperating marginChangeYear endedGross marginNet margin
2025-16056.0% 15909.6 pts down61.5%-15851.9%
2024-146.4% 57.1 pts up72.7%-104.7%
2023-203.5% 78.4 pts up59.3%-171.4%
2022-281.9%—37.8%-232.4%

Change is on the fiscal year before, in percentage points; a dash means that year is not on record. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Operating margin is operating income divided by revenue; gross margin does the same with gross profit, and net margin with net income.

How to read it

It shows how much of each unit of sales survives the cost of running the business — rising margins point to pricing power or scale, falling ones to pressure.

More on SLN

Silence Therapeutics plc, figure by figure

Silence Therapeutics plc (SLN) overview: price, valuation and scorecard

Silence Therapeutics plc operating margin: questions and answers

What is Silence Therapeutics plc's operating margin?

Silence Therapeutics plc (SLN) had an operating margin of -16056.0% in fiscal 2025 (the year ended December 31, 2025). That is 15909.6 percentage points lower than the -146.4% of fiscal 2024.

Is Silence Therapeutics plc's operating margin high or low compared with its own history?

The fiscal 2025 figure is no higher than in any of the 3 earlier fiscal years on record, whose median is -203.5%.

What are the highest and lowest operating margin figures on record for Silence Therapeutics plc?

Across the 4 fiscal years on record (2022–2025), the highest was -146.4% in fiscal 2024 and the lowest -16056.0% in fiscal 2025.

What are Silence Therapeutics plc's gross and net margins?

Gross margin was 61.5% in fiscal 2025. Net margin was -15851.9% in fiscal 2025.

How is Silence Therapeutics plc's operating margin calculated?

Operating margin is operating income divided by revenue; gross margin does the same with gross profit, and net margin with net income. For Silence Therapeutics plc it is on record here for 4 fiscal years, 2022 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Silence Therapeutics plc (SLN) operating margin”, data as of 18 November 2026. https://funkfolio.com/stock/SLN/operating-margin

Underlying data: Yahoo Finance.